US BROKER MOVES: AJG double upgraded at Barclays; ORCL upgraded at JPM

UPGRADES

Arthur J. Gallagher (AJG) upgraded from Underweight to Overweight at Barclays; PT $262.00 (prev. $247.00)
Apyx Medical (APYX) upgraded from Neutral to Buy at BTIG; PT $6.00
CrowdStrike (CRWD) upgraded from Hold to Buy at DZ Bank; PT $490.00
INmune Bio (INMB) upgraded from Neutral to Buy at Lucid Capital Markets; PT $9.00
Intuitive Surgical (ISRG) upgraded from Neutral to Buy at Citi; PT $590.00
NIO (NIO) upgraded from Neutral to Buy at Nomura/Instinet; PT $6.60 (prev. $8.40)
Nike (NKE) upgraded from Equalweight to Overweight at Barclays; PT $73.00 (prev. $64.00)
Novartis (NVS) upgraded from Hold to Buy at Argus; PT $180.00
Oracle (ORCL) upgraded from Neutral to Overweight at JPMorgan; PT $210.00
J.M. Smucker (SJM) upgraded from Market Perform to Outperform at Bernstein SocGen; PT $145.00 (prev. $121.00)
VTEX (VTEX) upgraded from Neutral to Outperform at Bradesco BBI; PT $5.00
Willis Towers Watson (WTW) upgraded from Underweight to Equalweight at Barclays; PT $341.00 (prev. $318.00)

DOWNGRADES

VICI Properties (VICI) downgraded from Outperform to Neutral at Mizuho; PT $30.00
Yext (YEXT) downgraded from Buy to Neutral at Roth/MKM; PT $6.00 (prev. $9.50)

INITIATIONS

Compass Diversified (CODI) initiated at Market Perform at Raymond James
JOYY Inc. (JOYY) initiated at Buy at UBS; PT $80.00
Ligand Pharmaceuticals (LGND) initiated at Buy at BofA Securities; PT $244.00
Alliant Energy (LNT) initiated at Outperform at RBC Capital; PT $82.00
Ocugen (OCGN) initiated at Outperform at Oppenheimer; PT $10.00